Zacks Research Issues Pessimistic Forecast for CL Earnings

Colgate-Palmolive (NYSE:CLFree Report) – Research analysts at Zacks Research decreased their Q2 2025 EPS estimates for shares of Colgate-Palmolive in a research report issued on Thursday, May 8th. Zacks Research analyst R. Lohia now expects that the company will post earnings per share of $0.89 for the quarter, down from their previous estimate of $0.94. The consensus estimate for Colgate-Palmolive’s current full-year earnings is $3.75 per share. Zacks Research also issued estimates for Colgate-Palmolive’s Q3 2025 earnings at $0.91 EPS, Q4 2025 earnings at $0.94 EPS, FY2025 earnings at $3.65 EPS, Q2 2026 earnings at $0.95 EPS, Q3 2026 earnings at $0.97 EPS, Q4 2026 earnings at $1.01 EPS, FY2026 earnings at $3.90 EPS, Q1 2027 earnings at $1.03 EPS and FY2027 earnings at $4.15 EPS.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its quarterly earnings results on Friday, April 25th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.86 by $0.05. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. The business had revenue of $4.91 billion for the quarter, compared to analysts’ expectations of $4.92 billion. During the same quarter last year, the firm earned $0.86 EPS. The firm’s revenue for the quarter was down 3.0% compared to the same quarter last year.

CL has been the topic of several other research reports. Citigroup lifted their target price on shares of Colgate-Palmolive from $103.00 to $108.00 and gave the stock a “buy” rating in a research report on Monday, April 28th. JPMorgan Chase & Co. lifted their target price on shares of Colgate-Palmolive from $95.00 to $103.00 and gave the stock an “overweight” rating in a research report on Monday, April 28th. Piper Sandler dropped their target price on shares of Colgate-Palmolive from $108.00 to $107.00 and set an “overweight” rating on the stock in a research report on Monday, March 31st. Raymond James reissued an “outperform” rating and set a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. Finally, Barclays dropped their target price on shares of Colgate-Palmolive from $89.00 to $86.00 and set an “equal weight” rating on the stock in a research report on Friday, April 11th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $102.39.

Get Our Latest Stock Analysis on CL

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $87.88 on Monday. Colgate-Palmolive has a 52 week low of $85.32 and a 52 week high of $109.30. The company’s 50 day moving average price is $92.05 and its two-hundred day moving average price is $91.40. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The stock has a market cap of $71.22 billion, a P/E ratio of 24.97, a P/E/G ratio of 4.20 and a beta of 0.39.

Colgate-Palmolive Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Thursday, April 17th will be given a dividend of $0.52 per share. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.50. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.37%. The ex-dividend date is Thursday, April 17th. Colgate-Palmolive’s payout ratio is 58.76%.

Colgate-Palmolive declared that its Board of Directors has approved a stock repurchase plan on Thursday, March 20th that permits the company to buyback $5.00 billion in shares. This buyback authorization permits the company to purchase up to 6.8% of its shares through open market purchases. Shares buyback plans are usually an indication that the company’s management believes its stock is undervalued.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in CL. Cornerstone Wealth Management LLC raised its stake in shares of Colgate-Palmolive by 1.2% during the first quarter. Cornerstone Wealth Management LLC now owns 9,035 shares of the company’s stock valued at $847,000 after acquiring an additional 110 shares during the last quarter. Axxcess Wealth Management LLC raised its stake in shares of Colgate-Palmolive by 0.3% during the fourth quarter. Axxcess Wealth Management LLC now owns 38,786 shares of the company’s stock valued at $3,526,000 after acquiring an additional 117 shares during the last quarter. Commonwealth Financial Services LLC raised its stake in shares of Colgate-Palmolive by 4.5% during the fourth quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company’s stock valued at $247,000 after acquiring an additional 118 shares during the last quarter. Wescott Financial Advisory Group LLC raised its stake in shares of Colgate-Palmolive by 3.5% during the fourth quarter. Wescott Financial Advisory Group LLC now owns 3,517 shares of the company’s stock valued at $320,000 after acquiring an additional 119 shares during the last quarter. Finally, D Orazio & Associates Inc. raised its stake in shares of Colgate-Palmolive by 4.2% during the fourth quarter. D Orazio & Associates Inc. now owns 2,982 shares of the company’s stock valued at $271,000 after acquiring an additional 120 shares during the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Company Profile

(Get Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Earnings History and Estimates for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.